Status:
COMPLETED
A Study of Subcutaneous C.E.R.A. for the Maintenance of Hemoglobin Levels in Participants With Chronic Renal Anemia Not on Dialysis.
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Anemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This single arm study will assess the efficacy and safety of subcutaneous C.E.R.A. when administered for the maintenance of hemoglobin levels in participants with chronic renal anemia, not on dialysis...
Eligibility Criteria
Inclusion
- Chronic renal anemia
- Stable darbepoetin alfa or epoetin beta therapy for past 8 weeks
Exclusion
- Transfusion of red blood cells during previous 8 weeks
- Poorly controlled hypertension requiring interruption of epoetin treatment in previous 6 months
- Acute or chronic bleeding requiring therapy within previous 8 weeks
Key Trial Info
Start Date :
March 27 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 9 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00642304
Start Date
March 27 2008
End Date
December 9 2009
Last Update
June 26 2018
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Twenteborg Ziekenhuis
Almelo, Netherlands, 7609 PP
2
Meander Mc, Locatie Lichtenberg; Dept of Lung Diseases
Amersfoort, Netherlands, 3818 ES
3
Bovenij Zkhs; Cardiologie Afd.
Amsterdam, Netherlands, 1034 CS
4
Wilhelmina Ziekenhuis; Inwendige Geneeskunde
Assen, Netherlands, 9401 RK